Venture Life Group (LON:VLG) Sets New 12-Month High – Still a Buy?

Venture Life Group plc (LON:VLGGet Free Report) hit a new 52-week high on Thursday . The stock traded as high as GBX 67 and last traded at GBX 66.25, with a volume of 326740 shares traded. The stock had previously closed at GBX 65.

Venture Life Group Stock Performance

The firm has a market capitalization of £84.54 million, a price-to-earnings ratio of -87.17, a P/E/G ratio of 5.67 and a beta of 0.30. The company has a 50-day moving average price of GBX 58.14 and a 200-day moving average price of GBX 57.15. The company has a quick ratio of 1.48, a current ratio of 2.22 and a debt-to-equity ratio of 28.45.

Venture Life Group (LON:VLGGet Free Report) last issued its quarterly earnings data on Tuesday, September 30th. The company reported GBX 0.83 earnings per share for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. As a group, equities research analysts forecast that Venture Life Group plc will post 6.1391542 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Mark Adams bought 88,999 shares of the stock in a transaction that occurred on Friday, October 3rd. The shares were purchased at an average cost of GBX 56 per share, with a total value of £49,839.44. 6.84% of the stock is owned by corporate insiders.

Venture Life Group Company Profile

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.

Read More

Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.